An article referencing ReachBio's new drug screening platform to discover therapeutic compounds that trigger the production of fetal hemoglobin (HbF) to treat sickle cell disease (SCD) and other blood disorders is prominently featured on the Sickle Cell Anemia News website. Please click the link to read the full article by Ana Pena, PhD.